Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones Life Science Investing News
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee Geography
Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights Life Science Investing News
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 Life Science Investing News
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women Life Science Investing News
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates Life Science Investing News
